103 related articles for article (PubMed ID: 2504834)
21. Evaluation of roxithromycin (RU-965) versus cephradine in pneumococcal pneumonia.
Zeluff BJ; Lowe P; Koornhof HJ; Gentry LO
Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):69-71. PubMed ID: 3132383
[TBL] [Abstract][Full Text] [Related]
22. [Multicenter study of the clinical efficacy and tolerance of roxithromycin compared to erythromycin ethylsuccinate in lower respiratory tract infections].
Bertrand A; Jonquet O; Sauvaget J
Pathol Biol (Paris); 1988 May; 36(5):544-7. PubMed ID: 3043354
[TBL] [Abstract][Full Text] [Related]
23. [Roxithromycin (RU 28965), a new macrolide effective against pulmonary infections].
Lachat JM; Anex JF; Regamey C
Schweiz Med Wochenschr; 1986 Dec; 116(49):1739-41. PubMed ID: 3810100
[TBL] [Abstract][Full Text] [Related]
24. [Clinical evaluation of TMS-19-Q, a new macrolide antibiotic, in otorhinolaryngological infections].
Baba S; Wada K; Hatano T; Murai K; Kinoshita H; Kawamura S; Sugita R; Fujimaki Y; Sanbe B; Ueda R
Jpn J Antibiot; 1985 Mar; 38(3):595-614. PubMed ID: 3897601
[TBL] [Abstract][Full Text] [Related]
25. [Miocamycin in the prevention and treatment of cutaneous infections in the emergency service].
Bertinieri G; Caser L; Ceffa G; Cortese P; Martina C; Riccardi G; Calogero G
Minerva Med; 1987 Nov; 78(21):1625-7. PubMed ID: 3500430
[TBL] [Abstract][Full Text] [Related]
26. Roxithromycin, a new macrolide antibiotic, in the treatment of infections in the lower respiratory tract: an overview.
Gentry LO
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():145-52. PubMed ID: 3323166
[TBL] [Abstract][Full Text] [Related]
27. A double-blind comparison of spiramycin and doxycycline in treatment of respiratory tract infections (pneumonia and suppurative bronchitis).
Bitsch M; Løken A
Chemioterapia; 1987 Jun; 6(2 Suppl):453-5. PubMed ID: 3334598
[No Abstract] [Full Text] [Related]
28. Roxithromycin compared with erythromycin against genitourinary chlamydial infections.
Worm AM; Hoff G; Kroon S; Petersen CS; Christensen JJ
Genitourin Med; 1989 Jan; 65(1):35-8. PubMed ID: 2646206
[TBL] [Abstract][Full Text] [Related]
29. Roxithromycin (RU 28965) in the treatment of respiratory tract infections.
Grassi C; Bertoletti R; De Rose V; Manara G; Mangiarotti P
Chemioterapia; 1987 Feb; 6(1):41-4. PubMed ID: 3103931
[TBL] [Abstract][Full Text] [Related]
30. In-vitro activity of roxithromycin against respiratory and skin pathogens.
Pechére JC; Auckenthaler R
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():1-5. PubMed ID: 3501424
[TBL] [Abstract][Full Text] [Related]
31. A simplified regimen for treatment of skin and soft tissue infections.
Caloza DL; Losi MJ; Ackerman HJ
Cutis; 1980 Feb; 25(2):222-4. PubMed ID: 6987042
[TBL] [Abstract][Full Text] [Related]
32. Clinical multicentre trial with josamycin propionate in paediatric patients.
Privitera G; Bonino S; Del Mastro S
Int J Clin Pharmacol Res; 1984; 4(3):201-7. PubMed ID: 6386705
[TBL] [Abstract][Full Text] [Related]
33. [Comparative double-blind evaluation of a new topical antibacterial agent, mupirocin, compared with placebo in the treatment of skin and soft tissue infections].
Colin M; Avon P
Pharmatherapeutica; 1988; 5(3):198-203. PubMed ID: 3129741
[TBL] [Abstract][Full Text] [Related]
34. A double-blind comparative study of ampicillin, co-trimoxazole and josamycin in anthraco-silicotic miners, assessed by transtracheal puncture.
Joly J; Ninane G; Kraytman M
J Antimicrob Chemother; 1977 Sep; 3(5):429-33. PubMed ID: 332681
[No Abstract] [Full Text] [Related]
35. Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections.
Ramirez-Ronda CH; Saavedra S; Rivera-Vázquez CR
Am J Med; 1987 Apr; 82(4A):220-3. PubMed ID: 3555040
[TBL] [Abstract][Full Text] [Related]
36. [Clinical experience with 9,3"-diacetylmidecamycin (MOM) in surgical field (author's transl)].
Yokoyama S; Saito T
Jpn J Antibiot; 1980 Oct; 33(10):985-8. PubMed ID: 6970825
[No Abstract] [Full Text] [Related]
37. [Laboratory and clinical studies of rokitamycin dry syrup in the field of pediatrics].
Kuno K; Nakao Y; Yamamoto N; Hayakawa F; Ishikawa H; Kimura H; Takeuchi H
Jpn J Antibiot; 1988 Jul; 41(7):875-84. PubMed ID: 3172461
[TBL] [Abstract][Full Text] [Related]
38. Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
Pérez-Ruvalcaba JA; Quintero-Pérez NP; Morales-Reyes JJ; Huitrón-Ramírez JA; Rodríguez-Chagollán JJ; Rodríguez-Noriega E
Am J Med; 1987 Apr; 82(4A):242-6. PubMed ID: 3555042
[TBL] [Abstract][Full Text] [Related]
39. Roxithromycin in the therapy of Streptococcus pyogenes throat infections.
Herron JM
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():139-44. PubMed ID: 3323165
[TBL] [Abstract][Full Text] [Related]
40. Clinical evaluation of roxithromycin in odontogenic orofacial infections.
Sasaki J
J Antimicrob Chemother; 1987 Nov; 20 Suppl B():167-70. PubMed ID: 3429383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
